Boothbay Fund Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,534
| Closed | -$117K | – | 1313 |
|
|
2025
Q1 | $117K | Buy |
+20,534
| New | +$117K | ﹤0.01% | 1051 |
|
|
2024
Q4 | – | Sell |
-66,030
| Closed | -$538K | – | 1407 |
|
|
2024
Q3 | $538K | Buy |
66,030
+60,149
| +1,023% | +$490K | 0.01% | 793 |
|
|
2024
Q2 | $78.6K | Buy |
5,881
+4,906
| +503% | +$65.6K | ﹤0.01% | 1210 |
|
|
2024
Q1 | $45.2K | Buy |
975
+225
| +30% | +$10.4K | ﹤0.01% | 1303 |
|
|
2023
Q4 | $50.7K | Sell |
750
-143
| -16% | -$9.67K | ﹤0.01% | 1354 |
|
|
2023
Q3 | $64.7K | Buy |
893
+11
| +1% | +$797 | ﹤0.01% | 1409 |
|
|
2023
Q2 | $65.6K | Hold |
882
| – | – | ﹤0.01% | 1434 |
|
|
2023
Q1 | $46.9K | Buy |
882
+257
| +41% | +$13.7K | ﹤0.01% | 1776 |
|
|
2022
Q4 | $42.3K | Buy |
+625
| New | +$42.3K | ﹤0.01% | 1641 |
|
|
2022
Q3 | – | Sell |
-850
| Closed | -$81K | – | 2011 |
|
|
2022
Q2 | $81K | Sell |
850
-5,160
| -86% | -$492K | ﹤0.01% | 1752 |
|
|
2022
Q1 | $969K | Buy |
6,010
+5,610
| +1,403% | +$905K | 0.02% | 742 |
|
|
2021
Q4 | $133K | Buy |
+400
| New | +$133K | ﹤0.01% | 1481 |
|